EAM
KYNB

Erste Asset Management’s Kyntra Bio KYNB Stock Holding History

Erste Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,732
Closed -$2.9M – 517
2021
Q1 		$2.9M Hold
3,732
– – 0.07% 230
2020
Q4 		$3.54M Hold
3,732
– – 0.1% 197
2020
Q3 		$3.88M Buy
3,732
+204
+6% +$220K 0.13% 173
2020
Q2 		$3.58M Hold
3,528
– – 0.14% 161
2020
Q1 		$3.09M Sell
3,528
-416
-11% -$414K 0.18% 141
2019
Q4 		$4.43M Buy
3,944
+996
+34% +$1.02M 0.2% 122
2019
Q3 		$2.79M Hold
2,948
– – 0.15% 149
2019
Q2 		$3.28M Hold
2,948
– – 0.17% 135
2019
Q1 		$4M Buy
2,948
+1,612
+121% +$2.19M 0.22% 109
2018
Q4 		$1.46M Buy
+1,336
New +$1.5M 0.1% 195

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Erste Asset Management's KYNB Position: Q2 2021 in Review

Erste Asset Management sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 3,732 shares — an estimated $2.9M sold.

Erste Asset Management first reported a position in KYNB in Q4 2018 and held it in 10 quarters. The position peaked at $4.43M in Q4 2019. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Erste Asset Management reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Erste Asset Management sold 3,732 Kyntra Bio shares in Q2 2021, an estimated $2.9M.
  • Erste Asset Management first reported a position in Kyntra Bio in Q4 2018 and held it in 10 quarters.
  • Erste Asset Management's Kyntra Bio position peaked at $4.43M in Q4 2019.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Erste Asset Management's 13F filing for Q2 2021, filed 25 Nov 2024.